Literature DB >> 8740549

Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.

A W Stitt1, I Fairweather.   

Abstract

The effects of the active sulphoxide metabolite of the fasciolicide triclabendazole (Fasinex, Ciba-Geigy) on the vitelline cells of Fasciola hepatica were determined in vitro by transmission electron microscopy using both intact flukes and tissue-slice material. At a triclabendazole concentration of 15 micrograms/ml the vitelline cells of intact flukes showed ultrastructural changes only after prolonged incubation periods (12-24 h). The changes observed were a swelling of the granular endoplasmic reticulum (GER) cisternae with decreased ribosomal covering in the intermediate-type cells and condensation of chromatin and disappearance of the nucleolus in the nucleus of the stem cell. Similar changes were evident more quickly (by 6 h) in whole flukes treated at the higher concentration of 50 micrograms/ml. The shell globule clusters were loosely packed in the intermediate type-2 cells, and the number of intermediate type-1 cells declined with more prolonged incubation. Disruption of the nurse-cell cytoplasm was also observed from 12 h onwards. After only 6 h incubation of tissue-slice material at 50 micrograms/ml, intermediate type-1 cells were absent, shell globule clusters in mature cells were loosely packed and the nurse-cell cytoplasm was badly disrupted. By 12 h the vitelline cells were vacuolated and grossly abnormal. The results are discussed in relation to postulated actions of triclabendazole against the microtubule component of the cytoskeleton and against protein synthesis in the fluke.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740549     DOI: 10.1007/s004360050122

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  10 in total

1.  Senna alexandrina Mill. induced ultrastructural changes on Hymenolepis diminuta.

Authors:  S Kundu; S Roy; S Nandi; B Ukil; Larisha Mawkhlieng Lyndem
Journal:  J Parasit Dis       Date:  2016-04-09

2.  In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78.

Authors:  Urs Duthaler; Thomas A Smith; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

3.  Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.

Authors:  S M Walker; B McKinstry; J C Boray; G P Brennan; A Trudgett; E M Hoey; H Fletcher; I Fairweather
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

4.  The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Jill Lawson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

5.  The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-08-09       Impact factor: 2.289

6.  Cassia alata L: potential role as anthelmintic agent against Hymenolepis diminuta.

Authors:  Suman Kundu; Saptarshi Roy; Larisha M Lyndem
Journal:  Parasitol Res       Date:  2012-05-11       Impact factor: 2.289

7.  Triclabendazole sulfoxide causes stage-dependent embryolethality in zebrafish and mouse in vitro.

Authors:  Nuria Boix; Elisabet Teixido; Marta Vila-Cejudo; Pedro Ortiz; Elena Ibáñez; Juan M Llobet; Marta Barenys
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro.

Authors:  Yosef Shrifi; Ali Farahnak; Abolfazle Golestani; Mohamad Reza Eshraghian; Ashkan Faridi; Mohamad Bagher Molaei Rad
Journal:  Iran J Parasitol       Date:  2014-03       Impact factor: 1.012

9.  Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.

Authors:  Santiago Radio; Santiago Fontenla; Victoria Solana; Anna C Matos Salim; Flávio Marcos Gomes Araújo; Pedro Ortiz; Cristian Hoban; Estefan Miranda; Valeria Gayo; Fabiano Sviatopolk-Mirsky Pais; Hugo Solana; Guilherme Oliveira; Pablo Smircich; José F Tort
Journal:  Parasit Vectors       Date:  2018-01-24       Impact factor: 3.876

10.  Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica.

Authors:  Ana Winters; Ivana Milic; Andrew Devitt; Alan Cookson; Chelsea N Davis; Peter M Brophy; Russell M Morphew
Journal:  Sci Rep       Date:  2020-08-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.